Global Pre Clinical Imaging Market Projected to Reach $797 Million at Rate of 8.2% by 2019

The growth of the global pre clinical imaging market is driven by factors such as development of technologically advanced hybrid preclinical imaging systems such as PET/CT, PET/MRI, and PET/SPECT/CT; growing acceptance of pre clinical imaging as a legitimate drug development tool; and rising volume of pre clinical imaging research. In addition, emerging markets offering lucrative growth and departure of major companies from pre clinical imaging systems market are creating new growth opportunities for the preclinical imaging systems and reagents manufacturers.

Nonetheless, declining NIH (National Institutes of Health) funding for life science research, high implementation cost of preclinical imaging devices, and high cost and data requirements for bringing new imaging technology are the key reasons hampering the growth of pre clinical imaging market.

Complete report of 84 market data tables & 65 figures spread through 184 pages and in-depth TOC on "Pre-Clinical Imaging (In-VIVO) Market " at .

Geographically, North America (comprising the U.S. and Canada) commands the largest share of36.2% of the global pre clinical imaging market in 2014, followed by Europe. The preclinical imaging market in North America is primarily driven by various factors high volume of preclinical research in this region, easy availability and accessibility of resources (such as radioactive tracers), and rising government funding for research and innovation in Canada.

However,declining funding budgets of the U.S. National Institutes of Health (NIH) for preclinical research studies and recent changes in the Canadian R&D tax credit program are negatively affecting the growth of pre clinical imaging market in North America.

Click here to get more discount on this report at .

In this report, the pre clinical imaging market has been segmented on the basis of modality(covering optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photo acoustic, and magnetic particle imaging systems), by type of reagents  (including nuclear imaging reagents, optical imaging reagents, MRI contrast agents, ultrasound contrast agents and CT contrast agents), and by region (North America, Europe, Asia Pacific, and Rest of the World).The optical imaging systems market is estimated to account for the largest share of the global pre clinical imaging systems market in 2014. However, the nuclear imaging systems segment is expected to grow at the highest rate during the forecast period. Factors such as development of technologically advanced hybrid nuclear imaging systems such as PET/MRI and PET/SPECT/CT and rising adoption of these devices in the pre clinical research are driving the grow of the preclinical nuclear imaging systems market.

The report provides qualitative insights about the key market shares, growth rates, and market drivers for all important subsegments. It maps market sizes and growth rates of each subsegment and identifies segments poised for rapid growth in each of the geographic segments. The report also includes company profiles of the market leaders.

Single user licence, sample copy of “Pre Clinical Imaging (In-VIVO) Market by Systems and Reagents (Optical Imaging, Micro-PET, Micro-SPECT, Micro-MRI, Micro-ultrasound, Computed Tomography, Photo Acoustic Imaging, Magnetic Particle Imaging, Multimodality Imaging) - Global Forecasts to 2019” research report can be requested at .

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on preclinical imaging products offered by the top 10 players in the preclinical imaging market. The report analyzes the pre clinical imaging market by modality and type of reagent across four geographies
  • Product Development/Innovation: Detailed insights on current and upcoming technologies, research and development activities, and new product launches in the pre clinical imaging market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various pre clinical systems and reagents across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the pre clinical systems and reagents market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the pre clinical systems and reagents market

About Us:

(Contact us @ / + 1 888 391 5441) is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.